News tagged with restless legs syndrome

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Apr 23, 2018
popularity4 comments 0

Purpose in life by day linked to better sleep at night

Having a good reason to get out of bed in the morning means you are more likely to sleep better at night with less sleep apnea and restless leg syndrome, reports a new Northwestern Medicine and Rush University Medical Center ...

Jul 10, 2017
popularity232 comments 0

Insomnia genes found

An international team of researchers has found, for the first time, seven risk genes for insomnia. With this finding the researchers have taken an important step towards the unravelling of the biological mechanisms that cause ...

Jun 12, 2017
popularity418 comments 0

Sensory stimuli control dopamine in the brain

Regardless of whether we are sitting in a loud aeroplane or walking through a quiet forest clearing, how humans perceive their environment depends on the stimuli. This, in turn, affects our behaviour – sometimes consciously, ...

Jan 13, 2017
popularity11 comments 0

Restless legs syndrome

Restless legs syndrome (RLS), also known as Wittmaack-Ekbom's syndrome, is a condition that is characterized by an irresistible urge to move one's body to stop uncomfortable or odd sensations. It most commonly affects the legs, but can also affect the arms or torso. Moving the affected body part modulates the sensations, providing temporary relief. RLS causes a sensation in the legs or arms that can most closely be compared to a burning, itching, or tickling sensation in the muscles. Some controversy surrounds the marketing of drug treatments for RLS.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed